Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
1,819,991
-
Share change
-
+140,828
-
Total reported value
-
$17,725,000
-
Price per share
-
$9.74
-
Number of holders
-
20
-
Value change
-
+$1,007,435
-
Number of buys
-
8
-
Number of sells
-
6
Institutional Holders of GALMED PHARMACEUTICALS LTD - SHS (GLMD) as of Q2 2014
As of 30 Jun 2014,
GALMED PHARMACEUTICALS LTD - SHS (GLMD) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,819,991 shares.
The largest 10 holders included
683 Capital Management, LLC, Pine River Capital Management L.P., DAFNA Capital Management LLC, Park West Asset Management LLC, SPHERA FUNDS MANAGEMENT LTD., Visium Asset Management, LP, LORD, ABBETT & CO. LLC, Granite Point Capital Management, L.P., PERCEPTIVE ADVISORS LLC, and Knoll Capital Management, LP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.